Aurinia Pharmaceuticals AUPH Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's total liabilities & equity?
- Aurinia Pharmaceuticals (AUPH) reported total liabilities & equity of $724M in Q1 2026.
- How has Aurinia Pharmaceuticals's total liabilities & equity changed year-over-year?
- Aurinia Pharmaceuticals's total liabilities & equity increased by 43.4% year-over-year, from $504.85M to $724M.
- What is the long-term trend for Aurinia Pharmaceuticals's total liabilities & equity?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's total liabilities & equity has grown at a 10.1% compound annual growth rate (CAGR), from $463.66M to $751.59M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.